Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection

Summary

This is a 2-part, 2-arm, Phase 2 , multicentre, randomized, double-blind, placebo-controlled study in adults with COVID-19 with gastrointestinal infection.

Timeline

Start

2021-04-30

Primary completion

2022-06-04

Completion

2023-09-10

Drugs

Indications